These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38465813)

  • 41. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
    Chukanova EI; Chukanova AS; Mamayeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam.
    Tran L; Alvarez XA; Le HA; Nguyen DA; Le T; Nguyen N; Nguyen T; Nguyen T; Vo T; Tran T; Duong C; Nguyen H; Nguyen S; Nguyen H; Le T; Nguyen M; Nguyen T
    CNS Neurol Disord Drug Targets; 2022; 21(7):621-630. PubMed ID: 34414874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
    Povarnina PY; Volkova AA; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2017 Dec; 164(2):173-176. PubMed ID: 29181667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)].
    Zavadenko NN; Suvorinova NY; Batysheva TT; Bykova OV; Platonova AN; Gaynetdinova DD; Levitina EV; Mashin VV; Vakula IN; Maximova NE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):75-86. PubMed ID: 35485068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experience with mexidol in neurological practice].
    Gromova OA; Torshin IY; Stakhovskaya LV; Pepelyaev EG; Semenov VA; Nazarenko AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):97-107. PubMed ID: 30499505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined neuroprotection in the treatment of post-stroke aphasia].
    Safronova MN; Kovalenko AV; Mizurkina OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):20-26. PubMed ID: 31464285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evolution in optimization of stroke treatment].
    Zhivolupov SA; Samartsev IN; Ivanova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8 Pt 2):49-58. PubMed ID: 23390656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients].
    Volchegorskiĭ IA; Rassokhina LM; Koliadich MI; Alekseev MI
    Eksp Klin Farmakol; 2011; 74(11):17-23. PubMed ID: 22288155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reminiscence therapy-based care program relieves post-stroke cognitive impairment, anxiety, and depression in acute ischemic stroke patients: a randomized, controlled study.
    Cheng C; Fan W; Liu C; Liu Y; Liu X
    Ir J Med Sci; 2021 Feb; 190(1):345-355. PubMed ID: 32578029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of patients with chronic cerebral ischemia: experience of using the combined neuroprotective drug Picamilon Ginkgo].
    Zakharov VV; Borodulina IV; Vakhnina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):95-103. PubMed ID: 36168693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An experience with neuroprotective therapy of primary open-angle glaucoma based on the use of different dosage forms of Mexidol].
    Leonova ES; Polyakov SV; Pozdnyakova МА; Yarygina ЕP; Semisynov SО
    Vestn Oftalmol; 2015; 131(6):91-94. PubMed ID: 26977733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histo- and cytoarchitectonics of the hippocampus in young rats injected with propofol and mexidol.
    Dubovay TK; Lobov MA; Dreval AA; Pashina NR; Pashin SS; Kuprin AV; Bolevich SB; Knazev AV; Panteleeva MV
    Bull Exp Biol Med; 2010 Oct; 149(4):471-3. PubMed ID: 21234446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [An influence of mexidol on the restoration of neurological deficit, increase of social adaptation and removal of neglect and push syndromes in stroke patients].
    Koval'chuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):52-7. PubMed ID: 22792750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mono- and combination therapy with the mexidol in young patients with cerebral angiodystonia].
    Dyakonova EN; Makerova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):52-60. PubMed ID: 30251978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke].
    Tanashyan MM; Raskurazhev AA; Zaslavskaya KI; Kuznetsova PI; Merkulova IY
    Ter Arkh; 2022 Aug; 94(6):748-755. PubMed ID: 36286852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of mexidol in the intensive treatment of acute severe ischemic stroke].
    Seregin VI; Dronova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3 Pt 2):85-87. PubMed ID: 26121002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of the effectiveness of neuroprotective therapy in restoring motor function in patients during the acute period of ischemic stroke].
    Minina YD; Zakharov AV; Poverennova IE; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):44-50. PubMed ID: 34693688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical characteristics and metabolic therapy of fatigue in the acute and early recovery periods of ischemic stroke].
    Tynterova AM; Belousova YD; Reznik EY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3. Vyp. 2):94-100. PubMed ID: 36950826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The efficacy of antioxidant treatment with mexidol forte in 250 patients with chronic cerebral venous insufficiency].
    Chukanova EI; Chukanova AS; Mamaeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):57-63. PubMed ID: 33834719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.